Aziyo Biologics (NASDAQ: AZYO)
Q2 2022 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED)2022-08-08 | ||||||
REV |
Q1 2022 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | -0.620 | -0.600 | 0.0200 | ||||
REV | 10.780M | 11.495M | 715.000K |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|
You can purchase shares of Aziyo Biologics (NASDAQ: AZYO) through any online brokerage.
Other companies in Aziyo Biologics’s space includes: Alzamend Neuro (NASDAQ:ALZN), Anixa Biosciences (NASDAQ:ANIX), Fortress Biotech (NASDAQ:FBIO), HOOKIPA Pharma (NASDAQ:HOOK) and Curis (NASDAQ:CRIS).
The latest price target for Aziyo Biologics (NASDAQ: AZYO) was reported by Cowen & Co. on Friday, March 4, 2022. The analyst firm set a price target for 13.00 expecting AZYO to rise to within 12 months (a possible 85.98% upside). 1 analyst firms have reported ratings in the last year.
The stock price for Aziyo Biologics (NASDAQ: AZYO) is $6.99 last updated Today at June 29, 2022, 8:00 PM UTC.
There are no upcoming dividends for Aziyo Biologics.
Aziyo Biologics’s Q2 earnings are confirmed for Monday, August 8, 2022.
There is no upcoming split for Aziyo Biologics.
Aziyo Biologics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.